We perform rigorous validation at all levels of development, from lab bench to scale-up and the final product, with materials characterization, in-vitro experiments, and clinical trials.
Large Pore Mesoporous Silica Induced Weight Loss in Obese Mice
(Nanomedicine, 2014)
Mesoporous Silica With Precisely Controlled Pores Reduces Food Efficiency and Suppresses Weight Gain in Mice
(Nanomedicine, 2020)
Oral intake of mesoporous silica is safe and well tolerated in male humans
(PLOS ONE, 2020)
Entrapping Digestive Enzymes with Engineered Mesoporous Silica Particles Reduces Metabolic Risk Factors in Humans
(Advanced Healthcare Materials, 2020)
Engineered mesoporous silica reduces long-term blood glucose, HbA1c, and improves metabolic parameters in prediabetics
(Nanomedicine, 2022)
Towards mesoporous silica as a pharmaceutical treatment for obesity - impact on lipid digestion and absorption
(European Journal of Pharmaceutics and Biopharmaceutics, 2022)
Mesoporous Silica Particles Retain Their Structure and Function while Passing through the Gastrointestinal Tracts of Mice and Humans
(Applied Materials & Interfaces, 2023)
Activity and Stability of Nanoconfined Alpha-Amylase in Mesoporous Silica
(ACS MATERIAL Au, 2023)
Thanks for subscribing!
This email has been registered!